Cost-Effectiveness of HCV Core Antigen versus PCR for Monitoring Treatment Response in DAAS-Treated Egyptian Patients
Background and study aim: PCR is currently the non-debatable proof for diagnosis of HCV infection as well as conclusion of treatment outcomes. HCV core antigen (HCVcAg) testing is a neglected, less expensive and less time-consuming test that’s presumed to achieve the same aims. The aim of this study...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Zagazig University, Faculty of Medicine, Endemic and Tropical Medicine Department
2020-06-01
|
| Edice: | Afro-Egyptian Journal of Infectious and Endemic Diseases |
| Témata: | |
| On-line přístup: | https://aeji.journals.ekb.eg/article_87096_bdf21a141987364e58cea1b98ee8b2ee.pdf |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|